EU/3/16/1784

Table of contents

About

On 18 November 2016, orphan designation (EU/3/16/1784) was granted by the European Commission to MipSalus ApS, Denmark, for particles comprised of methacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides (also called PHE-MIP) for the treatment of hyperphenylalaninaemia.

Key facts

Active substance
particles comprised of methacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides
Disease / condition
Treatment of hyperphenylalaninaemia
Date of first decision
18/11/2016
Outcome
Positive
EU designation number
EU/3/16/1784

Sponsor's contact details

MipSalus ApS
Agern Allé 3
2970 Hørsholm
Denmark
Tel. +45 36 92 16 40
E-mail: info@mipsalus.dk

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating